
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings is projecting total revenues of approximately $890 million for 2026, reflecting a robust 17% increase over preliminary 2025 revenues, and is recognized as a leading candidate for market share growth among spine surgeons. The company's recent performance demonstrated a strong year-over-year revenue growth of 25%, driven by a significant 24% increase in surgical procedure volume, alongside a positive adjusted EBITDA of $26 million that exceeded expectations. Additionally, the enhanced surgeon adoption rate of 26% and established territory revenue growth of 30% underscore the company's strong operational momentum and potential for continued margin expansion as it capitalizes on its innovative spine treatment technologies.
Bears say
Alphatec Holdings, Inc. is experiencing a decline in revenue growth expectations, with a projected 31% drop in revenue and lower-than-expected free cash flow, indicating potential challenges in achieving consistent financial performance. The company's growth outlook for the upcoming quarters suggests a deceleration, with sequential growth rates tapering off, which could impact investor sentiment and stock performance. Additionally, risks related to sales execution, competition in the spine market, and potential dilution from equity offerings pose significant concerns that could further undermine the company's financial stability.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares